1. Home
  2. HPE vs NTRA Comparison

HPE vs NTRA Comparison

Compare HPE & NTRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hewlett Packard Enterprise Company

HPE

Hewlett Packard Enterprise Company

N/A

Current Price

$21.62

Market Cap

31.0B

Sector

Technology

ML Signal

N/A

Logo Natera Inc.

NTRA

Natera Inc.

N/A

Current Price

$195.64

Market Cap

32.9B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
HPE
NTRA
Founded
1939
2003
Country
United States
United States
Employees
N/A
N/A
Industry
Retail: Computer Software & Peripheral Equipment
Medical Specialities
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
31.0B
32.9B
IPO Year
2015
2015

Fundamental Metrics

Financial Performance
Metric
HPE
NTRA
Price
$21.62
$195.64
Analyst Decision
Buy
Strong Buy
Analyst Count
18
14
Target Price
$26.44
$259.07
AVG Volume (30 Days)
14.4M
991.9K
Earning Date
06-03-2026
05-19-2026
Dividend Yield
2.70%
N/A
EPS Growth
N/A
0.65
EPS
0.31
N/A
Revenue
$34,296,000,000.00
$210,939,000.00
Revenue This Year
$20.24
$16.65
Revenue Next Year
$5.79
$19.22
P/E Ratio
$67.98
N/A
Revenue Growth
13.84
N/A
52 Week Low
$11.97
$125.38
52 Week High
$26.44
$256.36

Technical Indicators

Market Signals
Indicator
HPE
NTRA
Relative Strength Index (RSI) 49.40 38.71
Support Level $20.10 $194.03
Resistance Level $24.97 $251.09
Average True Range (ATR) 0.76 7.94
MACD 0.05 -0.31
Stochastic Oscillator 77.16 16.43

Price Performance

Historical Comparison
HPE
NTRA

About HPE Hewlett Packard Enterprise Company

Hewlett Packard Enterprise is an information technology vendor that provides hardware and software to enterprises. Its primary product lines are compute servers, storage arrays, and networking equipment; it also has a high-performance computing business. HPE's stated goal is to be a complete edge-to-cloud company. Its portfolio enables hybrid clouds and hyperconverged infrastructure.

About NTRA Natera Inc.

Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.

Share on Social Networks: